about
Perspectives on the mechanism of transcriptional regulation by long non-coding RNAsThe efficacy of generating three independent anti-HIV-1 siRNAs from a single U6 RNA Pol III-expressed long hairpin RNA.Design of RNAi hairpins for mutation-specific silencing of ataxin-7 and correction of a SCA7 phenotype.The 37kDa/67kDa laminin receptor acts as a receptor for Aβ42 internalization.Progress in the use of RNA interference as a therapy for chronic hepatitis B virus infection.Long non-coding RNA targeting and transcriptional de-repressionInhibition of hepatitis B virus replication in vivo using lipoplexes containing altritol-modified antiviral siRNAs.Cell-specific RNA aptamer against human CCR5 specifically targets HIV-1 susceptible cells and inhibits HIV-1 infectivity.The biogenesis and characterization of mammalian microRNAs of mirtron origin.The therapeutic application of CRISPR/Cas9 technologies for HIV.Impact of sustained RNAi-mediated suppression of cellular cofactor Tat-SF1 on HIV-1 replication in CD4+ T cells.Progress and prospects: RNA-based therapies for treatment of HIV infection.Short non-coding RNA biology and neurodegenerative disorders: novel disease targets and therapeutics.Anti-LRP/LR specific antibodies and shRNAs impede amyloid beta shedding in Alzheimer's disease.Anti-LRP/LR specific antibody IgG1-iS18 and knock-down of LRP/LR by shRNAs rescue cells from Aβ42 induced cytotoxicityThe oncogenic TBX3 is a downstream target and mediator of the TGF-β1 signaling pathwaySmall RNA-induced transcriptional gene regulation in mammals mechanisms, therapeutic applications, and scope within the genome.HIV Latency and the noncoding RNA therapeutic landscape.Quantification of nascent transcription by bromouridine immunocapture nuclear run-on RT-qPCR.Pathogenic effects of Rift Valley fever virus NSs gene are alleviated in cultured cells by expressed antiviral short hairpin RNAs.Inhibition of hepatitis B virus replication with linear DNA sequences expressing antiviral micro-RNA shuttles.The inhibitory efficacy of RNA POL III-expressed long hairpin RNAs targeted to untranslated regions of the HIV-1 5' long terminal repeat.Are viral-encoded microRNAs mediating latent HIV-1 infection?Silencing of HIV-1 subtype C primary isolates by expressed small hairpin RNAs targeted to gag.Construction of mismatched inverted repeat (IR) silencing vectors for maximizing IR stability and effective gene silencing in plants.A new world order: tailored gene targeting and regulation using CRISPR.Therapeutic aptamers march on.The antisense strand of small interfering RNAs directs histone methylation and transcriptional gene silencing in human cells.Comparative single-turnover kinetic analyses of trans-cleaving hammerhead ribozymes with naturally derived non-conserved sequence motifs.Construction of effective inverted repeat silencing constructs using sodium bisulfite treatment coupled with strand-specific PCR.Chromosomal contact permits transcription between coregulated genes.Effective anti-hepatitis B virus hammerhead ribozymes derived from multimeric precursors.
P50
Q27000736-084BBB55-5D9D-445E-908F-97DC31243681Q33348656-3348EA21-6B32-43A6-9E7D-AD9E99A23D08Q33507519-99AD81FC-35D6-4DED-BB47-9585141CDC89Q33840258-34A30271-2B5D-4E51-B0FA-8C2E842593CCQ33865784-1B489612-AE7F-42B0-8BE6-4F678BA8EC98Q34326761-C5A5EBEE-D8BA-4014-BA9C-060371384853Q35029188-DA13FA34-8548-4A27-B808-F2DBE1A7B625Q35205365-2AF7897B-2EA8-41D7-B768-F3F5689AC479Q35633635-78A0BC7B-F694-4550-8B76-0E073481C954Q36089328-8AE61DD1-33D2-4B62-83C7-224CAC65A564Q36437368-785CD482-86A0-47CB-A019-2DBB02FB0C6EQ36868504-EA3E46D9-AC85-4E34-92EB-EFE270883638Q37134134-D361CE50-73AD-4C7A-8B45-453D8A216B82Q37182132-E0F19B35-5AB1-43A6-AF41-10C4D8FBF444Q37182136-12E93E7F-C35F-47D5-AA00-AF9CB5228F1CQ37306208-D76837BD-8330-4D6B-B1C3-9E6489265D89Q37918644-09C8524C-7D48-4395-BDA6-72287152FF54Q38372337-3CD99203-BCCE-457F-B024-CDF2D7EB0148Q38852230-8B9F291F-1537-4937-B199-49F2AADE3801Q39442255-612597D3-DCE4-488B-8C27-E6D0C5E433D0Q39803079-0A44EDFF-8331-4B8F-B226-3F1ADB227842Q40076053-649C2DE7-45A6-4F68-AFBE-8EA137587E30Q40255594-74E814BA-8D69-4857-99D6-95CCF76A3A4AQ40278977-814F4336-A5E3-4711-A2A3-599D7793B2E1Q42157377-6D5C1882-C6B9-4D04-8E58-678BCF0408ADQ42561610-96D2F61B-711E-454A-BBAE-43C3A2529B9BQ42980557-E2BB7C9F-F845-49AC-B944-C6396DC8104EQ43207523-AD369181-C487-4B00-9E41-5C56E74312CBQ43829750-CB43A1C3-45C3-44CF-9CD3-B07A8C47D198Q43904991-332759E2-0394-4646-ACAB-D259F1C2C5D8Q44177693-46260914-69D1-4FEE-83AA-B152B624239EQ45404665-1B2B22DE-2D8A-46F4-BD94-DB9DCD54562B
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Marc S. Weinberg
@ast
Marc S. Weinberg
@en
Marc S. Weinberg
@es
Marc S. Weinberg
@nl
Marc S. Weinberg
@sl
type
label
Marc S. Weinberg
@ast
Marc S. Weinberg
@en
Marc S. Weinberg
@es
Marc S. Weinberg
@nl
Marc S. Weinberg
@sl
prefLabel
Marc S. Weinberg
@ast
Marc S. Weinberg
@en
Marc S. Weinberg
@es
Marc S. Weinberg
@nl
Marc S. Weinberg
@sl
P1053
B-4669-2009
P106
P1153
35303792500
P21
P31
P3829
P496
0000-0002-1997-2171